Oculus Innovative Sciences, Inc. (OCLS) - Medical Equipment - Deals and Alliances Profile

Date: August 22, 2016
Pages: 39
Price:
US$ 250.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: OB8E07FC79BEN
Leaflet:

Download PDF Leaflet

Oculus Innovative Sciences, Inc. (OCLS) - Medical Equipment - Deals and Alliances Profile
Summary

Oculus Innovative Sciences, Inc. (Oculus) is a specialty pharmaceutical company that develops, manufactures and markets prescription and non-prescription products for the treatment of dermatological conditions and advanced tissue care. The company offers products for advanced wound management, nursing home and home healthcare, wound and skin care, women’s healthcare products, Microcyn skin and wound care products, Regenacyn advanced scar management hydrogel and animal healthcare. Oculus develops its products based on shelf-stable microcyn technology platform. It sells its products through OTC stores. The company has its presence in Europe, China, India, Mexico, Caribbean, Middle East, Singapore and Malaysia. Oculus is headquartered in Petaluma, California, the US.

Oculus Innovative Sciences, Inc. (OCLS) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope
  • Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
  • Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
  • Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
  • Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
  • Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
  • Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
  • Business Description - A brief description of the company's operations.
  • Key Employees - A list of the key executives of the company.
  • Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
  • Key Competitors - A list of the key competitors of the company.
  • Key Recent Developments - A brief on recent news about the company.
Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
  • The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion/divestiture strategy
  • The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
  • Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
  • The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
  • Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
  • Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company.
Oculus Innovative Sciences, Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016
Oculus Innovative Sciences, Inc., Medical Equipment Deals By Type, 2010 to YTD 2016
Oculus Innovative Sciences, Inc., Medical Equipment, Deals By Region, 2010 to YTD 2016
Oculus Innovative Sciences, Inc., Medical Equipment, Deals By Market, 2010 to YTD 2016
Oculus Innovative Sciences, Inc., Medical Equipment, Deals Summary, 2010 to YTD 2016
Oculus Innovative Sciences, Inc., Medical Equipment, Deal Details
Partnerships
Oculus Innovative Sciences Enters Into Licensing Agreement With National Institutes of Health
Oculus Innovative Sciences Enters into Agreement with Lipogrid
Oculus Innovative Sciences Enters Into Licensing Agreement With More Pharma
Oculus Innovative Enters Into Licensing Agreement With Eloquest Healthcare
Equity Offering
Oculus Innovative Sciences Completes Public Offering Of Common Stock For US$3.5 Million
Oculus Innovative Sciences Completes Private Placement Of Preferred Stock For US$1 Million
Oculus Innovative Sciences Completes Private Placement Of Shares For US$2 Million
Oculus Innovative Sciences Completes Registered Direct Offering Of Shares For US$2.1 Million
Oculus Innovative Sciences Announces Public Offering Of Common Stock
Oculus Innovative Sciences Announces Public Offering Of Common Stock
Oculus Innovative Sciences, Inc. - Key Competitors
Key Employees
Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Financial Announcements
Jul 28, 2016: Oculus Innovative Sciences Reports Financial Results for First Quarter of Fiscal Year 2017
Jul 06, 2016: Oculus Innovative Sciences Announces Record Monthly and Quarterly Prescription Data
Jun 16, 2016: Oculus Innovative Sciences Reports Financial Results for Fiscal Year 2016 and Fourth Quarter Ending March 31, 2016
Feb 04, 2016: Oculus Innovative Sciences Reports Third Quarter Financial Results
Nov 05, 2015: Oculus Innovative Sciences Reports Financial Results for the Second Quarter of Fiscal Year 2016
Jul 30, 2015: Oculus Innovative Sciences Reports Financial Results for the First Quarter of Fiscal Year 2016C
Jun 11, 2015: Oculus Innovative Sciences Reports Financial Results for the Fourth Quarter of Fiscal Year 2015
Corporate Communications
Apr 12, 2016: Versant Ventures Strengthens Global Team
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Oculus Innovative Sciences, Inc., Medical Equipment, Key Facts, 2016
Oculus Innovative Sciences, Inc., Medical Equipment, Deals Summary, 2010 to YTD 2016
Oculus Innovative Sciences, Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016
Oculus Innovative Sciences, Inc., Medical Equipment Deals By Type, 2010 to YTD 2016
Oculus Innovative Sciences, Inc., Medical Equipment, Deals By Region, 2010 to YTD 2016
Oculus Innovative Sciences, Inc., Deals By Market, 2010 to YTD 2016
Oculus Innovative Sciences, Inc., Medical Equipment, Deals Summary, 2010 to YTD 2016
Oculus Innovative Sciences Enters Into Licensing Agreement With National Institutes of Health
Oculus Innovative Sciences Enters into Agreement with Lipogrid
Oculus Innovative Sciences Enters Into Licensing Agreement With More Pharma
Oculus Innovative Enters Into Licensing Agreement With Eloquest Healthcare
Oculus Innovative Sciences Completes Public Offering Of Common Stock For US$3.5 Million
Oculus Innovative Sciences Completes Private Placement Of Preferred Stock For US$1 Million
Oculus Innovative Sciences Completes Private Placement Of Shares For US$2 Million
Oculus Innovative Sciences Completes Registered Direct Offering Of Shares For US$2.1 Million
Oculus Innovative Sciences Announces Public Offering Of Common Stock
Oculus Innovative Sciences Announces Public Offering Of Common Stock
Oculus Innovative Sciences, Inc., Key Competitors
Oculus Innovative Sciences, Inc., Key Employees
Oculus Innovative Sciences, Inc., Subsidiaries

LIST OF FIGURES

Oculus Innovative Sciences, Inc., Medical Equipment, Deals by Type, 2010 to YTD 2016
Oculus Innovative Sciences, Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016
Oculus Innovative Sciences, Inc., Medical Equipment, Deals By Region, 2010 to YTD 2016
Oculus Innovative Sciences, Inc., Medical Equipment, Deals By Market, 2010 to YTD 2016
Oculus Innovative Sciences, Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016
Oculus Innovative Sciences, Inc., Medical Equipment, Deals by Type, 2010 to YTD 2016
Oculus Innovative Sciences, Inc., Medical Equipment, Deals By Region, 2010 to YTD 2016
Oculus Innovative Sciences, Inc., Medical Equipment, Deals by Market, 2010 to YTD 2016
Skip to top


Ask Your Question

Oculus Innovative Sciences, Inc. (OCLS) - Medical Equipment - Deals and Alliances Profile
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: